Review
doi: 10.1016/j.ccr.2004.09.006.
Focus on kidney cancer
Affiliations
- PMID: 15380513
- DOI: 10.1016/j.ccr.2004.09.006
Item in Clipboard
Review
Focus on kidney cancer
Cancer Cell.
2004 Sep.
Free article
Erratum in
- Cancer Cell. 2004 Oct;6(4):423
No abstract available
Similar articles
-
Analysis of two single nucleotide polymorphisms and loss of heterozygosity detection in the VHL gene in Chinese patients with sporadic renal cell carcinoma.Chin Med J (Engl). 2005 Aug 5;118(15):1291-4. Chin Med J (Engl). 2005. PMID: 16117884 No abstract available.
-
[Genetic backgrounds of renal cell carcinoma].Nihon Rinsho. 2006 Feb;64 Suppl 2:593-6. Nihon Rinsho. 2006. PMID: 16523961 Review. Japanese. No abstract available.
-
Treatment of renal-cell cancer by transplantation of allogeneic stem cells.N Engl J Med. 2001 Jan 11;344(2):137; author reply 138. N Engl J Med. 2001. PMID: 11188410 No abstract available.
-
The role of von Hippel-Lindau tumor suppressor protein and hypoxia in renal clear cell carcinoma.Am J Physiol Renal Physiol. 2004 Jul;287(1):F1-6. doi: 10.1152/ajprenal.00424.2003. Am J Physiol Renal Physiol. 2004. PMID: 15180922 Review.
-
Germline and somatic mutations in von Hippel-Lindau disease gene and its significance in the development of kidney cancer.Contrib Nephrol. 1999;128:1-10. doi: 10.1159/000059976. Contrib Nephrol. 1999. PMID: 10597373 Review. No abstract available.
Cited by
-
Renal cell carcinoma.Cancer Biomark. 2010;9(1-6):461-73. doi: 10.3233/CBM-2011-0176. Cancer Biomark. 2010. PMID: 22112490 Free PMC article. Review.
-
Genetic basis for kidney cancer: opportunity for disease-specific approaches to therapy.Expert Opin Biol Ther. 2008 Jun;8(6):779-90. doi: 10.1517/14712598.8.6.779. Expert Opin Biol Ther. 2008. PMID: 18476789 Free PMC article.
-
High Level of Anaphylatoxin C5a Predicts Poor Clinical Outcome in Patients with Clear Cell Renal Cell Carcinoma.Sci Rep. 2016 Jul 6;6:29177. doi: 10.1038/srep29177. Sci Rep. 2016. PMID: 27381421 Free PMC article.
-
Patient-reported outcomes for axitinib vs sorafenib in metastatic renal cell carcinoma: phase III (AXIS) trial.Br J Cancer. 2013 Apr 30;108(8):1571-8. doi: 10.1038/bjc.2013.145. Epub 2013 Apr 11. Br J Cancer. 2013. PMID: 23579211 Free PMC article. Clinical Trial.
-
The clinical implications of the genetics of renal cell carcinoma.Urol Oncol. 2009 Mar-Apr;27(2):131-6. doi: 10.1016/j.urolonc.2008.11.001. Urol Oncol. 2009. PMID: 19285230 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
